Used as a key intermediate in the synthesis of sedative and anxiolytic pharmaceuticals, particularly in the development of pyrazolopyridine derivatives with central nervous system activity. It serves in the preparation of selective GABA-A receptor modulators, which are investigated for treating anxiety, insomnia, and epilepsy. Its structure allows for functionalization at multiple sites, enabling fine-tuning of pharmacokinetic properties in drug design. Commonly employed in medicinal chemistry research for generating novel heterocyclic compounds with potential CNS depressant effects.